home.aspx
 
EVENTS

Symposium on Advanced Wound Care Fall
SYMPOSIUM ON ADVANCED WOUND CARE FALL
October 30-01, 2020
The Symposium on Advanced Wound Care Fall meeting (SAWC Fall) serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the foremost experts in wound care to improve patient outcomes thro...

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...

Castle Creek Pharmaceuticals

SHARESHARESHARE
Castle Creek Pharma is a high growth biopharmaceutical company founded by an experienced team of pharmaceutical entrepreneurs.
SHARESHARESHARE

RELATED NEWS


Social media covers a range of different online, interactive sites, such as Facebook and Twitter, and these different platforms have a considerable reach and following, with many sites boasting millions of users and daily visits. Despite the rapidly growing popularity of social media, the pharmaceutical industry....

READ MORE

Medicare could soon cover CAR-T therapies under new proposals from the US’ Centers for Medicare & Medicaid Services (CMS), which aim to also gather real-world evidence to eventually inform expanded coverage. Currently, local Medicare Administrative Contractors have discretion over whether to pay for CAR-T treatments. The proposed National Coverage Determination would require Medicare to cover the therapy nationwide when it is offered in a CMS-approved registry or clinical study, in whi...

READ MORE

Japan has become the first country to approve Roche’s personalised cancer drug Rozlytrek (entrectinib). Roche added entrectinib to its pipeline through its $1.7 billion buyout of Ignyta at the end of 2017 in a move that brought it into competition with Bayer and its newly acquired targeted therapy specialist unit, Loxo. Rozlytrek is a “tumour agnostic” oral medicine that targets any advanced recurrent solid tumour with neurotrophic tyrosine receptor kinase (NTRK) fusion mutatio...

READ MORE

Medicare and its beneficiaries could have saved an estimated $17.7 billion over a seven-year period on generic versions of older medicines instead of paying for newer, chemically similar but more expensive brand-name drugs, according to a study published in the Annals of Internal Medicine last month. The study was conducted as part of the Collaboration for Research Integrity and Transparency at Yale Law School, funded by the Laura and John Arnold Foundation. The intent was to estimate the potent...

READ MORE

The death rate from cancer in the US has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society. As of 2016, the cancer death rate for men and women combined had fallen 27% from its peak in 1991. This decline translates to about 1.5% per year and more than 2.6 million deaths avoided between 1991 and 2016. The drop in cancer mortality is mostly due to steady reductions in smoking and advances in early detection and treatment. But not al...

READ MORE

Eli Lilly’s experimental breast cancer drug abemaciclib has been granted a priority review by US regulators for two indications, and is now on track to be filed in Europe later this year. The US Food and Drug Administration will consider the drug’s use as monotherapy for patients with hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer who had prior endocrine therapy and chemotherapy for metastatic disease, and also in combination wit...

READ MORE

EVENTS

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.